Israeli researcher receives EU grant for development of 'electronic nose'

An Israeli researcher has been awarded a grant of € 1.73 million by the EU under its Marie Curie Excellence programme for the development of an 'electronic nose' that can sniff out cancer.

Dr Hossam Haick of the Israel Institute of Technology received the award as part of the EU's efforts to strengthen and encourage young promising scientists.

Dr Haick is 31 years old and also the recipient of the largest grant ever received from the EU by an Israeli researcher. He will be working on artificial olfactory systems or 'electronic noses' aimed at sniffing out and diagnosing cancer at the earliest possible stage before it spreads.

"Realisation of the research goal will enable creating an instrument based on nanometre-sized sensors that can diagnose different cancers and even determine at what stage the disease is," explains Dr Haick. "The diagnosis can be carried out at a very early stage even before the tumour has begun to spread. Thus, treatment will be immediate and will destroy the disease at its inception."

Electronic noses are one example of a growing research area called biomimetics, or biomimicry, which involves human-made applications patterned on natural phenomena.

As an odour is composed of molecules, each of which has a specific size and shape, each of these molecules has a receptor of a corresponding size and shape in the human nose. When a specific receptor receives a molecule, it sends a signal to the brain and the brain identifies the smell associated with that particular molecule. Electronic noses based on the biological model work in a similar manner, substituting sensors for the receptors, and transmitting the signal to a program for processing, instead of the brain.

Dr Haick intends to develop sensor arrays made of nanomaterials, understanding the fundamental chemical, physical, and electrical properties of these nanomaterials and the signal mechanism of these sensors.

He will also be developing the smallest versions of these electronic noses; the 'e-nose on chip', which is a single computer chip containing both the sensors and the processing components.

In addition, to targeting the early diagnosis, detection and screening of a disease, artificial olfactory systems are used in environmental-monitoring, the food industries and security.

For further information, please visit: Technion - Israel Institute of Technology

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

AI Tool Helps Predict Relapse of Pediatr…

Artificial intelligence (AI) shows tremendous promise for analyzing vast medical imaging datasets and identifying patterns that may be missed by human observers. AI-assisted interpretation of brain scans may help improve...

Detecting Lung Cancer 4 Months Earlier a…

GPs may soon be able to identify patients with an increased risk of lung cancer up to 4 months earlier than is currently the case. The GP should be able...

Infectious Disease Surveillance Platform…

The Biothreats Emergence, Analysis and Communications Network (BEACON) leverages advanced artificial intelligence (AI), large language models (LLMs) and a network of globally based experts to rapidly collect, analyze, and disseminate...

NHS, Councils, and Housing could Share N…

A new technology partnership formally announced, could help NHS, local government, and housing organisations collaborate to create an unprecedented understanding of the risks and needs of people in their care...

Children's Health Ireland to Transf…

Healthcare teams responsible for paediatric care in Ireland are to save significant time in accessing important diagnostic imaging and reports, with the help of a new agreement with medical imaging...

AI-Powered Analysis of Stent Healing

Each year, more than three million people worldwide are treated with stents to open blocked blood vessels caused by heart disease. However, monitoring the healing process after implantation remains a...

An AI Tool Grounded in Evidence-Based Me…

A powerful clinical artificial intelligence tool developed by University at Buffalo biomedical informatics researchers has demonstrated remarkable accuracy on all three parts of the United States Medical Licensing Exam (Step...

Right Patient, Right Dose, Right Time

While artificial intelligence (AI) has shown promising potential, much of its use has remained theoretical or retrospective. Turning its potential into real-world healthcare outcomes, researchers at the Yong Loo Lin...

AXREM and BHTA Name Highland as 'Fu…

Hosted by trade associations AXREM and the British Healthcare Trades Association (BHTA), 'The Future of MedTech - Innovating for Tomorrow', will allow delegates to engage with speakers from the government...